Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected caucasians and African Americans

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1799-1802

  Mann, Dean L ^a   Garner, Robin P ^b   Dayhoff, Deborah E ^b   Cao, Kai ^b   Fernández Viña, Marcelo A ^b   Davis, Charles ^b   Aronson, Naomi ^b   Ruiz, Nancy ^b   Birx, Deborah L ^b   Michael, Nelson L ^b  

^a UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAUCASIAN; DISEASE ASSOCIATION; DISEASE COURSE; GENOTYPE; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; SCORING SYSTEM; SURVIVAL; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICAN CONTINENTAL ANCESTRY GROUP; ATP-BINDING CASSETTE TRANSPORTERS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE-FREE SURVIVAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENES, MHC CLASS I; GENES, MHC CLASS II; GENOTYPE; HIV ENVELOPE PROTEIN GP160; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HIV-1; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; RECOMBINANT PROTEINS; SURVIVAL RATE; VARIATION (GENETICS); VIRAL LOAD;

EID: 17344370075     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314519     Document Type: Article

References (15)

1. Daar ES, Mougdil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary HIV-1 infection. N Engl J Med 1991;324:961-4.
2. Mellors JW, Kingsley LA, Rinaldo CRJ, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
3. Safrit JT, Andrews CA, Zhu T, Ho DD, Koup RA. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J Exp Med 1994;179:463-71.
4. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary HIV-1 syndrome. J Virol 1994;68:4650-5.
5. Lamhamedi-Cherradi S, Culmann-Penciolelli OB, Ly TD, Goujard C, Guillet JG, Gomard E. Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection. AIDS 1995;9:421-6.
6. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-16.
7. Harrer T, Harrer E, Kalams SA, et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. J Immunol 1996;156:2616-23.
8. Goulder PJR, Sewell AK, Lalloo DG, et al. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical sibling with HLA-A*0201 are influenced by epitope mutation. J Exp Med 1997;185:1423-33.
9. Kaslow RA, Carrington M, Apple R, et al. Influence of combination of genes in the major histocompatibility complex and the course of HIV-1 infection. Nat Med 1996;2:405-11.
10. Birx DL, Davis C, Ruiz N, et al. Results of a phase II double-blinded, multi-center, placebo-controlled HIV therapeutic vaccine trial. In: Program and abstracts: XI International Conference on AIDS (Vancouver, Canada). Vancouver: XI International Conference on AIDS Society, 1996.
11. Carrington M, Colonna M, Spies T, Stephens JC, Mann DL. Haplotypic variation of the transporter associated with antigen processing (TAP) genes and their extension of HLA class II region haplotypes. Immunogenetics 1993;37:266-73.
12. Carrington MH, Miller T, White MB, et al. Typing of HLA-DQA1 and - DQB1 using DNA single-strand conformation polymorphism. Hum Immunol 1992;33:208-12.
13. SAS Institute. SAS user's guide: statistics (version 5). Cary, NC: SAS Institute, 1990.
14. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 1997;3:338-410.
15. Nelson GW, Kaslow R, Mann DL. Frequency of HLA allele-specific peptide motifs in HIV-1 protein correlates with the allele's association with relative rates of disease progression after HIV-1 infection. Proc Natl Acad Sci USA 1997;94:9802-7.